2011. ISPOR Annual International Meeting – Overview of Primary Endpoints, Progression Free-Survival (PFS) and Overall Survival (OS) for Non-Small Cell Lung Cancer (NSCLC): Their Value in Treatment Decisions and Patient Care

Heron L, De Castro Carpeño J, Chouaid C, Vergnenègre A, Bischo HG, Walzer S. Overview of Primary Endpoints, Progression Free-Survival (PFS) and Overall Survival (OS) for Non-Small Cell Lung Cancer (NSCLC): Their Value in Treatment Decisions and Patient Care. Value Health. 2011 May;14(3):A177-A178. Presented at: ISPOR 16th Annual International Meeting; May 25, 2011; Baltimore, USA.